Business Wire

W Green Pay (WGP) - The Global Solution to Greenhouse Gas (GHG) Reduction

Jaa

W-Foundation (www.gcrfund.org/en/), the philanthropic foundation behind HOOXI campaign, Global Nature Conservation Campaign, introduces W Green Pay (WGP), the ERC20-compliant blockchain, to reward HOOXI app users for their Greenhouse Gas (GHG) reduction efforts.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180530005620/en/

(Graphic: W-Foundation)

(Graphic: W-Foundation)

Korean government officials attended and shared congratulatory messages at the “Nation-wide Public Movement to Reduce GHG Emission (HOOXI Campaign)” Declaration and Committee Inauguration Ceremony held at National Assembly in December 2017 and April 2018: Kim, Eunkyung (Minister, Ministry of Environment), Kim, Hyunmee (Minister, Ministry of Land, Infrastructure, and Transport), Jeong, Segyun (Chairman, National Assembly), Choo, Miae (Representative Member, Democratic Party – the ruling party), Im, Jongseong (Member, National Assembly), and many more.

Sustainable business model: Globally first to reward individuals in carbon market

HOOXI app will aggregate the GHG reduction data of individuals, for which Korean government will allocate NEPs (National Emission Permit: trades at approximately US$20 for 1 ton). With revenue from the allocated NEPs traded at the market, HOOXI app will fund its operations and the ongoing market purchase of WGP to reward users.

HOOXI app: Gamification features with instantaneous rewards (WGP)

HOOXI app offers a variety of functional advantages.

First, HOOXI app is a ground-breaking platform digitizing public participation and rewards for GHG reduction efforts.

Second, HOOXI app is a mobile app-based environmental encyclopedia. HOOXI app provides easily executable ways to reduce GHG in everyday life, and information on environmental impacts driven by user participation.

Third, HOOXI app uses artificial intelligence (AI) to analyze the profile of each user and customize missions for their lifestyle, age, gender, occupation. Based on these analyzed information, tailored daily, weekly and monthly GHG reduction missions will be sent to users.

Fourth, HOOXI app incentivizes users through its gamification features. HOOXI app can track users’ daily exercise stats as Fitbit does and suggest location-based missions as Pokémon Go’s does. Based on their completed mission points, users can track their ranks and compete within and between their groups, i.e. friends, companies, and the entire country.

Fifth, think of the likes on your Instagram posts — we are constantly endeavoring to achieve and be rewarded instantaneously. With its social networking service features, HOOXI app encourages users to get on the app daily to earn rewards.

Using WGP: Shopping, cashback and more

Users can use WGP tokens in different channels. W-Foundation’s HOOXI mall and partnered-online and offline retail stores will accept WGP for payment. WGP-affiliated credit card with Korean commercial banks will also be launched, with WGP as a payback system for credit card users.

W-Foundation continues to work on HOOXI app’s development as well as WGP’s utility. “As more users join, HOOXI app will extract a greater value from the carbon market and enhance WGP’s value and liquidity to its holders,” said Youree Lee, CEO of W-Foundation.

Subscribe on W Green Pay (WGP) website ( www.wpay.sg ), for promotions and exclusive updates.

Contact information

Media Enquiries
W-Foundation
Michael Lee
michael@wfoundation.kr

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 14:00Tiedote

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 11:10Tiedote

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 18:13Tiedote

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 17:00Tiedote

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 16:41Tiedote

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 15:00Tiedote

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme